Cosmetic Safety Enhancement Act Advances In US House, Still Without Preemption
Approved by the House Energy and Commerce Health Subcommittee on 11 March, H.R. 5279 still lacks any concrete provisions regarding federal preemption of state and local requirements, though bill author and full committee chair Frank Pallone, D-NJ, remains committed to discussions on the subject. He recognized preemption as “a major issue that I know we have to deal with.”
You may also be interested in...
Fragrance Creators Association Pronounces Finished Product Firms ‘Active’ Members; CEO Ahmed Discusses
Finished product manufacturers that have joined the Fragrance Creators Association in recent years will be elevated from Associate to Active members under a “strategic pivot” announced by the trade group on 21 July. The move should promote greater collaboration throughout the value chain to better inform and serve consumers, CEO Farah Ahmed says.
The FDA must report to the House Appropriations Committee on any work toward defining “natural” cosmetics and on the health effects of talc, asbestos and lead in cosmetic products. The committee’s 2021 FDA spending bill report also cites concerns about skin-lightening products containing “dangerous levels of mercury and hydroquinone.”
The renamed Expert Panel for Cosmetic Ingredient Safety has its own website now, which includes the conflict of interest statement its members are expected to sign. The panel will meet virtually 8-9 June to consider a raft of ingredient reports in various stages of development at Cosmetic Ingredient Review.